WikiPatents - Community Patent Review
Create Free Account  |  License or Sell Your Patent  |  WikiPatents Marketplace  |  WikiPatents Blog
Username:  Password:  
    
Advanced Search
Unsaturated cyclic amido-substituted ether compounds and preparation process thereof    
United States Patent4649219   
Link to this pagehttp://www.wikipatents.com/4649219.html
Inventor(s)Itoh; Hiroshi (Yokohama, JP); Nitta; Atsuhiko (Yokohama, JP); Tanaka; Tomio (Tokyo, JP); Kamio; Hideo (Odawara, JP)
AbstractDisclosed herein are novel unsaturated cyclic amide-substituted ether compounds having a wide range of utility in crosslinking agents, adhesives, paints, raw materials for hygroscopic resins, etc. These compounds are prepared by reacting cyclic halogen-substituted ether compounds with unsaturated amide compounds in the presence of a strong basic substance in an aprotic polar solvent.
   














 Title Information Submit all comments and votes
 
Patent Text Patent PDF Print Page Summary File History
Plain text PDF images Print Summary File History
Drawing from US Patent 4649219
Unsaturated cyclic amido-substituted ether compounds and preparation

     process thereof - US Patent 4649219 Drawing
Unsaturated cyclic amido-substituted ether compounds and preparation process thereof
Inventor     Itoh; Hiroshi (Yokohama, JP); Nitta; Atsuhiko (Yokohama, JP); Tanaka; Tomio (Tokyo, JP); Kamio; Hideo (Odawara, JP)
Owner/Assignee     Mitsui Toatsu Chemicals, Incorporated (Tokyo, JP)
Patent assignment
All assignments
Publication Date     March 10, 1987
Application Number     06/708,568
PAIR File History     Application Data   Transaction History
Image File Wrapper   Patent Term   Fees
Litigation
Filing Date     March 6, 1985
US Classification     564/207 526/288 526/292.95 526/298 526/304 558/414
Int'l Classification     C07C 103/38
Examiner     Hoke; Veronica P.
Assistant Examiner    
Attorney/Law Firm     Fisher, Christen & Sabol
Address
Parent Case    
Priority Data     Mar 13, 1984[JP]59-46532
USPTO Field of Search     524/167 524/171 524/217 524/218 524/219 524/220 524/222 524/224 524/226 525/279 525/281 525/290 525/291 525/296 526/256 526/257 526/259 526/260 526/261 526/263 526/283 526/284 526/287 526/288 526/292.5 526/304 560/38 560/39 560/41 564/153 564/154 564/155 564/157 564/204 564/207
Patent Tags     unsaturated cyclic amido-substituted ether compounds preparation
   
Enter a comma (,) or semicolon (;) between multiple tag words/phrases.
Describe this patent:
 Amusing   
 Clever   
 Complex   
 Efficient   
 Historic   
 Important   
 Innovative   
 Interesting   
 Practical   
 Simple   
[no votes]
Patent WIKI

Share information and news about this patent, including information and news about the technology, inventors, company, ligation and licensing.

 References Submit all comments and votes
 
*references marked with an asterisk below are user-added references
 U.S. References
 
Add a new US reference:  
ReferenceRelevancyCommentsReferenceRelevancyComments
3784565



[0 after 0 votes]
3928499



[0 after 0 votes]
3796773



[0 after 0 votes]
2773063



[0 after 0 votes]
3037056



[0 after 0 votes]
3280189



[0 after 0 votes]
3297623



[0 after 0 votes]
3315012



[0 after 0 votes]
3374289



[0 after 0 votes]
3433835



[0 after 0 votes]
3562327



[0 after 0 votes]
3627831



[0 after 0 votes]
3652478



[0 after 0 votes]
3705136



[0 after 0 votes]
3766144



[0 after 0 votes]
4233430
Jacquet
526/259
Nov,1980

[0 after 0 votes]
4172933
Turner
526/244
Oct,1979

[0 after 0 votes]
4134916
Moss
564/204
Jan,1979

[0 after 0 votes]
4129545
Sunamori
524/555
Dec,1978

[0 after 0 votes]
4021404
Cox
524/210
May,1977

[0 after 0 votes]
3993877
Sendyk
379/357.04
Nov,1976

[0 after 0 votes]
 Foreign References
 Other References
 Market Review Submit all comments and votes
   
Market Size
Estimate the gross annual revenues of the relevant market sector:
> $10B
$5B - $10B
$2B - $5B
$500M - $2B
$100M - $500M
$10M - $100M
$1M - $10M
$500K - $1M
$100K - $500K
< $100K
[No votes]
$0
 
$0   $2.5B   $5B   $7.5B   $10B
Market Share
Estimate the percentage of the relevant market sector this invention will capture:
75% - 100%
50% - 74.99%
25% - 49.99%
10 - 24.99%
5 - 9.99%
2 - 4.99%
1 - 1.99%
< 1%
[No votes]
0.0%
 
0%   25%   50%   75%   100%
Reasonable Royalty
What percentage of gross sales should the inventor or assignee be paid?
75% - 100%
50% - 74.99%
25% - 49.99%
10 - 24.99%
5 - 9.99%
2 - 4.99%
1 - 1.99%
< 1%
[No votes]
0.0%
 
0%   25%   50%   75%   100%
Public's "Guesstimation" of Royalty Value
Market SizeN/A[No votes]
xMarket ShareN/A[No votes]
xReasonable RoyaltyN/A[No votes]

N/A

License Availablity
If you are NOT the owner or assignee, answer here:
Yes, license is available for purchase

No, license is not currently available



[No votes]
License Availablity
If you ARE the owner or assignee, answer here:
Yes, license is available for purchase

No, license is not currently available



[No votes]
Competitive Advantage
Does this invention have a significant competitive advantage over similar technologies?
Yes

No



[No votes]
Most helpful competitive advantage comment
[No comments]

Commercial Alternatives
Are there viable commercial alternatives for this invention?
Yes

No



[No votes]
Most helpful commercial alternative comment
[No comments]

 Technical Review Submit all comments and votes
 Claims Submit all comments and votes
 


What is claimed is:

1. Unsaturated cyclic amido-substituted ether compound represented by the following general formula (I): ##STR36## wherein: R.sub.1 is an aromatic ring; Z is an alkylene group having 1 or 2 carbon atoms, an alkenylene group having 3 carbon atoms, an oxyalkylene group represented by the general formula --O--C.sub.x H2.sub.x --, wherein x is an integer of 1 or 2, or an aminoalkylene group represented by the general formula: ##STR37## wherein y and z are each an integer of 2; A is a halogen atom, a hydroxyl group, an oxo group, a cyano group, a nitro group, a mercapto group, a sulfo group, an alkyl group having 1 to 9 carbon atoms, an alkenyl group having 3 carbon atoms, an aminoalkyl group represented by the general formula: ##STR38## wherein R' and R" each are an alkyl group having 1 or 2 carbon atoms, or a group represented by the general formula RO-- or RCO--, wherein R is an alkyl group having 1 carbon atom or an aryl group; R.sub.2 is a hydrogen atom or a methyl group; l is an integer of 0 to 3; m is an integer of 4 to 20; .alpha. and .beta. each stand for an integer of 0 or 1, with the proviso that .alpha.+.beta.=1.

2. The unsaturated cyclic amido-substituted ether compound as claimed in claim 1 wherein the carbocyclic aromatic ring is selected from the group consisting of benzene, naphthalene and anthracene.

3. The unsaturated cyclic amido-substituted ether compound as claimed in claim 1 wherein A is a halogen atom, an oxo group, a nitro group, an alkyl group having 1 to 9 carbon atoms, an alkenyl group having 3 carbon atoms, an aminoalkenyl group represented by the general formula: ##STR39## wherein R'.sub.1 and R" each are an alkyl group having 2 carbon atoms, a group represented by the general formula RO-- or RCO--, wherein R is an alkyl group having 1 carbon atom or an aryl group.

4. The unsaturated cyclic amido-substituted ether compound as claimed in claim 1 wherein m stands for an integer of 4 to 12.
 Description Submit all comments and votes
 


BACKGROUND OF THE INVENTION

(a) Field of the Invention

This invention relates to unsaturated cyclic amido-substituted ether compounds and their preparation process. More specifically, it relates to unsaturated cyclic amido-substituted ether compounds, in each of which at least one hydroxyl group of an OH-substituted cyclic compound has been substituted by an unsaturated amidopolymethylenoxy group, and their preparation process. The unsaturated cyclic amido-substituted ether compounds of this invention can be used in crosslinking agents, adhesives, paints and raw materials for hygroscopic resins as well as in various other fields.

(b) Description of the Prior Art

Cyclic compounds have permitted relatively easy introduction of various substituent groups owing to their cyclic structures. This feature is not seen in aliphatic compounds, whereby making them suitable as raw materials for functional materials. When using them as functional materials, it is however necessary to increase their molecular weights, generally by fixing them to side chains of monomers so that they are insolubilized.

No general method has however been established to date for the fixing of such cyclic compounds into high molecular compounds. Except for a few examples seen among styrene derivatives, the functionality of these cyclic compounds has thus not been fully utilized under the circumstances.

As skeletal compounds of fixing base materials, N-substituted amide derivatives have some advantageous characteristics unseen in other skeletal compounds such as esters, ethers and hydrocarbon derivatives, including their better compatibility with a variety of materials, their resistance to hydrolysis, etc. compared with such other skeletal compounds.

SUMMARY OF THE INVENTION

Interested with a variety of functionality which cyclic compounds have, the present inventors have carried out an extensive investigation with a view toward fixing such cyclic compounds and developing functional polymers containing amido groups in their skeletal structures. As a result, they have found unsaturated cyclic amido-substituted ether compounds in each of which a hydroxyl group of an OH-substituted cyclic compound and the amido group of acrylic amide or methacrylic amide are bonded by way of a polymethylene group and their preparation process, leading to completion of this invention.

The unsaturated cyclic amido-substituted ether compounds can be prepared by reacting cyclic halogen-substituted ether compounds with unsaturated amide compounds in the presence of a strong basic substance in an aprotic polar solvent.

The compounds of this invention are unsaturated cyclic amido-substituted ether compounds each represented by the following general formula (I): ##STR1## wherein R.sub.1 and R.sub.1 ' are each a cyclic group; Z means an alkylene group having 1-5 carbon atoms, an alkenylene group having 2-5 carbon atoms, an oxyalkylene group represented by the general formula --O--C.sub.x H.sub.2x).sub.r (r: integer of 1-50; x: integer of 1-5) or an aminoalkylene group represented by the general formula ##STR2## A and A' each denotes a halogen atom, hydroxyl group, oxo group, cyano group, nitro group, mercapto group, sulfo group or a salt thereof, an alkyl group having 1- 20 carbon atoms, an alkenyl group having 2-15 carbon atoms, a haloalkyl group having 1-20 carbon atoms, an amino or aminoalkyl group represented by the general formula ##STR3## hydrogen atom, lower alkyl group or .omega.-unsaturated amidopolymethylene group represented by the general formula ##STR4## n being an integer of 4-20and R.sub.3 being a hydrogen atom or methyl group; R"': lower alkylene group), a group represented by the general formula RO--, RCO-- or RCOO-- (R: alkyl group having 1-20 carbon atoms, alkenyl group having 2-15 carbon atoms or aryl group), a group represented by the general formula --COOR (R.sub.4 hydrogen atom, alkali metal atom, alkyl group having 1-20 carbon atoms, alkenyl group having 2-15 carbon atoms, aryl group or .omega.-unsaturated amidopolymethylene group represented by the general formula ##STR5## p being an integer of 4-20 and R.sub.5 being a hydrogen atom or methyl group; B stands for an oxygen atom, carbonyl group, thio group, sulfonyl group, azo group, alkylene group having 1-5 carbon atoms or alkenylene group having 2-5 carbon atoms; R.sub.2 denotes a hydrogen atom or methyl group; l and l' are each an integer of 0-5; (A)l and (A')l', each means a combination of 0-5 atoms or groups which may be the same or different and are selected from the group of the atoms and groups defined above for A and A'; m stands for an integer of 4-20; .alpha., .alpha.', .beta. and .beta.' stand each for an integer of 0-4 with a proviso that all of .alpha.,.alpha.', .beta. and .beta.' do not stand for 0 at the same time; and q stands for 0 or 1. They are novel compounds which have not been reported in any literatures.

The compounds of this invention can each be prepared by reacting a cyclic halogen-substituted ether compound represented by the following general formula (II): ##STR6## wherein R.sub.1, R.sub.1 ', Z, A, A', B, q, m, l, l', .alpha.,.alpha.', .beta. and .beta.' have the same meaning as defined above and X denotes a halogen atom with an unsaturated amide compound represented by the following general formula (III): ##STR7## wherein R.sup.2 has the same meaning as defined above, in the presence of a strong basic substance in an aprotic polar solvent.

The cyclic halogen-substituted ether compounds which are raw materials required for the preparation of the compounds of this invention can be obtained with ease in accordance with a process already proposed by the present inventors, namely, through reactions between OH-substituted cyclic compounds and dihaloalkanes.

The following advantageous effects can thus be brought about inter alia from the practice of this invention.

(i) The process of this invention makes use of OH-substituted cyclic compounds as raw materials. Therefore, an extremely wide variety of compounds can be applied as mentioned above. The preparation process of this invention has an extremely high applicability.

Therefore, a variety of functionality may be expected on the basis of various interactions. As specific interactions, may be mentioned ionic interaction, electrostatic interaction, charge-transfer interaction, .pi.--.pi. interaction, van der Waals interaction and so on.

Furthermore, multi-functional monomers such as crosslinking agents can also be prepared with ease by using multi-substituted OH-substituted cyclic compounds as raw materials. New functions which are unseen in conventional crosslinking agents have been found as new types of crosslinking agents.

(ii) Since an amido group and a cyclic group are bonded together via a polymethylenoxy group and the chain length of the polymethylenoxy group can be controlled, flexibility can be imparted to polymers of the compounds of this invention and the degree of the thus-imparted flexibility can be controlled. Furthermore, the distance of bonding to an amido group can be controlled depending on the molecular size of each cyclic compound. This allows to introduce the amido group in the cyclic compound without difficulties.

(iii) An amido group is contained as a skeletal structure. Accordingly, each of the compounds of this invention has intermolecular secondary bond owing to the hydrogen bond between amido groups. Various properties have thus been improved including mechanical properties as raw materials.

DETAILED DESCRIPTION OF THE INVENTION

In the compound of this invention represented by the general formula (I), the halogen indicated by A is chlorine, bromine, iodine or fluorine. In the general formula (II), the halogen represented by X is chlorine, bromine or iodine. The carbon ring shown by R.sub.1 is an aromatic or alicyclic ring or a condensed or combined ring thereof. The hetero atom which makes up the ring of the heterocyclic ring indicated by R.sub.1 is oxygen, nitrogen or sulfur. Where two or more ring-forming hetero atoms are contained, they may be different from each other or one another. For example, monoheterocyclic rings, carbocyclic rings, condensed heterocyclic rings of heterocyclic rings, heterocyclic spiro rings, heterocyclic crosslinking rings, etc. may be mentioned.

As aromatic rings, may be mentioned monocyclic and condensed polycyclic rings such as benzene, naphthalene, anthracene, pentacene, heptacene and the like, and those formed of 2-4 of these rings which are bonded together. As alicyclic rings, may be mentioned monocyclic rings such as cycloalkanes, cycloalkenes, cycloalkadienes, cycloalkatrienes, etc., dimers of cycloalkadienes, hydrides of condensed aromatic polycyclic rings and those formed of 2-4 of such rings which are bonded together. As such condensed carbocyclic rings, there are dicyclic and tricyclic rings such as indene and fluorene as well as partial hydrides of condensed polycyclic aromatic compounds. Also included are hydrocarbon compounds formed of the above three types of rings combined together and those formed by substituting hetero atoms such as oxo group to ring-forming carbons.

Where A means a haloalkyl group, the above-described alkyl group contains at least one halogen atom substituted thereto. Where two or more halogen atoms are contained, they may be different halogen atoms.

The compounds of this invention are more specifically those obtained using, as basic skeletal structures, those formed of carbocyclic rings such as aromatic or alicyclic rings or their condensed or combined rings, or heterocyclic rings such as monoheterocyclic, condensed heterocyclic rings of carbocyclic rings or heterocyclic rings, heterocyclic spiro rings, crosslinked heterocyclic rings and hydroxyl groups bonded to the carbocyclic rings or heterocyclic rings either directly or via alkylene, alkenylene, oxyalkylene and/or aminoalkylene groups and substituting at least one of the hydroxyl groups with .omega.-unsaturated amidopolymethylenoxy group or groups. Also included are those obtained by introducing such substituent groups as referred to above with respect to A into carbocyclic rings or heterocyclic rings.

Certain representative examples of the compounds according to this invention will hereinafter be given by way of example. Since an extremely wide variety of compounds are included in the compounds of this invention, exemplary listing of compounds will first be made by changing R.sub.1, R.sub.1 ', Z, A, A', B, l, l', .alpha., .alpha.', .beta., and .beta.' and q in various ways while setting m and R.sub.2 respectively at 4 and a hydrogen atom in the general formula (1) for the sake of simplified exemplification. Then, further exemplary listing will be made by changing R.sub.2 to a hydrogen atom or methyl group and m 4-20 while setting R.sub.1 at a benzene ring, .alpha., .alpha.' and .beta.' respectively at 0, q at 0, and l' and l respectively at 0.

Among substituted derivatives of compounds which contained OH-substituted carbocyclic rings, illustrative of substituted derivatives of alicyclic monohyric alcohols include:

N-(4-Cyclobutoxybutyl)acrylic amide;

N-(4-Cyclopentyloxybutyl)acrylic amide;

N-(4-Cylohexyloxybutyl)acrylic amide;

N-[4-(1-Methylcyclopentyloxy)butyl]acrylic amide;

N-[4-(2-Cyclohexenyloxy)butyl]acrylic amide;

N-(4-Cycloheptyloxybutyl)acrylic amide;

N-[4-(Cyclohexylmethoxy)butyl]acrylic amide;

N-[4-(2-Cyclopentylethoxy)butyl]acrylic amide;

N-[4-(4-Methylcyclohexyloxy)butyl]acrylic amide;

N-[4-(2-Cyclohexylethoxy)butyl]acrylic amide;

N-(4-Cyclooctyloxybutyl)acrylic amide;

N-[4-(2,5-Dimethylcyclohexyloxy)butyl]acrylic amide;

N-[4-(3,5-Dimethylcyclohexyloxy)butyl]acrylic amide;

N-[4-(1-Ethynylcyclohexyloxy)butyl]acrylic amide;

N-[4-(2-n-Propylcyclohexyloxy)butyl]acrylic amide;

N-[4-(3,3,5-Trimethylcyclohexyloxy)butyl]acrylic amide;

N-(4-Dicyclopentadienyloxybutyl)acrylic amide;

2-(4-Acrylamidobutoxy)adamantane;

2-(4-Acrylamidobutoxy)-1,7,7-trimethylbicyclo[

2.2.1]heptane;

N-[4-(5-Methyl-2-(1-methylvinyl)cyclohexyloxy)butyl]acrylic amide;

N-[4-(Dimethyl-(4-methyl-3-cyclohexenyl)methoxybutyl]acrylic amide;

N-[4-(1-Methyl-4-(1-methylvinyl)cyclohexyloxy)butyl]acrylic amide;

N-[4-(1-Methyl-4-isopropylidenecyclohexyloxy)butyl]acrylic amide;

N-[4-(4-tert-butylcyclohexyloxy)butyl]acrylic amide;

N-[4-(5-Methyl-2-isopropylcyclohexyloxy)butyl]acrylic amide;

1-(4-Actylamidobutoxymethyl)adamantane;

N-(4-Cyclododecyloxybutyl)acrylic amide;

N-[4-(2-Cyclohexylcyclohexyloxy)butyl]acrylic amide;

N-[4-(4-Cyclohexylcyclohexyloxy)butyl]acrylic amide;

3-(4-Acrylamidobutoxy)-3-cholestane;

3-(4-Acrylamidobutoxy)cholestane;

3-(4-Acrylamidobutoxy)stigmasta-5,22-diene;

3-(4-Acrylamidobutoxy)-6-stigmastene;

3-(4-Acrylamidobutoxy)lanosta-8,24-diene;

N-[4-(2-Chlorocyclohexyloxy)butyl]acrylic amide;

N-[4-(5-Oxo-2-methyl-1-cyclopentenyloxy)butyl]acrylic amide;

3-(4-Acrylamidobutoxy)-5-androsten-17-one;

17-(4-Acrylamidobutoxy)-4-androsten-3-one;

3-(4-Acrylamidobutoxy)-5-androstan-17-one;

17-(4-Acrylamidobutoxy)-5-androstan-3-one;

17-(4-Acrylamidobutoxy)-17-methyl-4-androsten-3-one;

17-(4-Acrylamidobutoxy)-17-ethynyl-4-androsten-3-one;

11-(4-Acrylamidobutoxy)progesterone;

3-(4-Acrylamidobutoxy)-5-pregnen-20-one;

21-Acetoxy-17-(4-acrylamidobutoxy)-4-pregnen-3,11,20-trione;

17-(Acrylamidobutoxy)-3-benzoyloxyestra-1,3,5(10)-triene; and the like.

As substituted derivatives of monohydric alcohols which contain aromatic rings, may for example be mentioned:

N-(4-Phenoxybutyl)acrylic amide;

N-(4-Benzyloxybutyl)acrylic amide;

N-[4-(2-Methylphenoxy)butyl]acrylic amide;

N-[4-(3-Methylphenoxy)butyl]acrylic amide;

N-[4-(4-Methylphenoxy)butyl]acrylic amide;

N-[4-(1-Phenylethoxy)butyl]acrylic amide;

N-[4-(2-Phenylethoxy)butyl]acrylic amide;

N-[4-(2,4-Dimethylphenoxy)butyl]acrylic amide;

N-[4-(3,5-Dimethylphenoxy)butyl]acrylic amide;

N-[4-(3-Ethylphenoxy)butyl]acrylic amide;

N-[4-(4-Ethylphenoxy)butyl]acrylic amide;

N-[4-(4-Methylbenzyloxy)butyl]acrylic amide;

N-[4-(1-Methyl-2-phenylethoxy)butyl]acrylic amide;

N-[4-(1-Methyl-1-phenylethoxy)butyl]acrylic amide;

N-[4-(3-Phenylpropoxy)butyl]acrylic amide;

N-[4-(4-Isopropylphenoxy)butyl]acrylic amide;

N-[4-(2-n-Propylphenoxy)butyl]acrylic amide;

N-[4-(4-n-Propylphenoxy)butyl]acrylic amide;

N-[4-(2,3,5-Trimethylphenoxy)butyl]acrylic amide;

N-[4-(3,4,5-Trimethylphenoxy)butyl]acrylic amide;

N-[4-(2-Allylphenoxy)butyl]acrylic amide;

N-[4-(1-(4-Methylphenyl)ethoxy)butyl]acrylic amide;

N-[4-(3-Phenyl-2-propenyloxy)butyl]acrylic amide;

N-[4-(1-Phenyl-2-propenyloxy)butyl]acrylic amide;

1-(4-Acrylamidobutoxy)indane;

2-(4-Acrylamidobutoxy)indane;

5-(4-Acrylamidobutoxy)indane;

N-[4-(1,1-Dimethyl-2-phenylethoxy)butyl]acrylic amide;

N-[4-(4-n-Butylphenoxy)butyl]acrylic amide;

N-[4-(2-sec-Butylphenoxy)butyl]acrylic amide;

N-[4-(4-sec-Butylphenoxy)butyl]acrylic amide;

N-[4-(2-tert-Butylphenoxy)butyl]acrylic amide;

N-[4-(3-tert-Butylphenoxy)butyl]acrylic amide;

N-[4-(4-tert-Butylphenoxy)butyl]acrylic amide;

N-[4-(1-Methyl-3-phenylpropoxy)butyl]acrylic amide;

N-[4-(2-Methyl-5-isopropylphenoxy)butyl]acrylic amide;

N-[4-(2,3,5,6-Tetramethylphenoxy)butyl]acrylic amide;

N-[4-(3-Isopropylbenzyloxy)butyl]acrylic amide;

1-(4-Acrylamidobutoxy)naphthalene;

2-(4-Acrylamidobutoxy)naphthalene;

2-(4-Acrylamidobutoxy)-5,6,7,8-tetrahydronaphthalene;

N-[4-(1,1-Dimethyl-3-phenylpropoxy)butyl]acrylic amide;

N-[4-(4-n-Pentylphenoxy)butyl]acrylic amide;

N-[4-(4-(1,1-Dimethylpropyl)phenoxy)butyl]acrylic amide;

N-[4-(2-tert-Butyl-6-methylphenoxy)butyl]acrylic amide;

N-[4-(2,6-Diisopropylphenoxy)butyl]acrylic amide;

N-[4-(6-tert-Butyl-2,4-dimethylphenoxy)butyl]acrylic amide;

N-[4-(2-Cyclohexylphenoxy)butyl]acrylic amide;

N-[4-(3-Cyclohexylphenoxy)butyl]acrylic amide;

N-[4-(4-Cyclohexylphenoxy)butyl]acrylic amide;

N-[4-(2-Phenylphenoxy)butyl]acrylic amide;

N-[4-(3-Phenylphenoxy)butyl]acrylic amide;

N-[4-(4-Phenylphenoxy)butyl]acrylic amide;

N-[4-(Diphenylmethoxy)butyl]acrylic amide;

N-[4-(4-Benzylphenoxy)butyl]acrylic amide;

N-[4-(1,1-Diphenylethoxy)butyl]acrylic amide;

N-[4-(1,2-Diphenylethoxy)butyl]acrylic amide;

N-[4-(2,4-Di-tert-butylphenoxy)butyl]acrylic amide;

N-[4-(2,6-Di-tert-butylphenoxy)butyl]acrylic amide;

N-[4-(4-(1,1,3,3-Tetramethylbutyl)phenoxy)butyl]acrylic amide;

N-[4-(4-Nonylphenoxy)butyl]acrylic amide;

N-[4-(2,6-Di-tert-butyl-4-methylphenoxy)butyl]acrylic amide;

N-[4-(4-(1-Methyl-1-phenylethyl)phenoxy)butyl]acrylic amide;

N-[4-(4-tert-butyl-2,6-diisopropylphenoxy)butyl]acrylic amide;

N-[4-(2,4,6-Tri-sec-butylphenoxy)butyl]acrylic amide;

N-[4-(2,4,6-Tri-tert-butylphenoxy)butyl]acrylic amide;

N-[4-(Triphenylmethoxy)butyl]acrylic amide; and the like.

As substituted derivatives obtained by substituting one or more halogen or haloalkyl groups to the aromatic rings of the above-described compounds, may for example be mentioned:

N-[4-(3-Fluorophenoxy)butyl]acrylic amide;

N-[4-(4-Fluorophenoxy)butyl]acrylic amide;

N-[4-(2-Chlorophenoxy)butyl]acrylic amide;

N-[4-(4-Chlorophenoxy)butyl]acrylic amide;

N-[4-(2-Bromophenoxy)butyl]acrylic amide;

N-[4-(3-Bromophenoxy)butyl]acrylic amide;

N-[4-(4-Iodophenoxy)butyl]acrylic amide;

N-[4-(2,3-Dichlorophenoxy)butyl]acrylic amide;

N-[4-(2,4-Dichlorophenoxy)butyl]acrylic amide;

N-[4-(2,6-Dichlorophenoxy)butyl]acrylic amide;

N-[4-(3,4-Dichlorophenoxy)butyl]acrylic amide;

N-[4-(3,5-Dichlorophenoxy)butyl]acrylic amide;

N-[4-(2,4-Dibromophenoxy)butyl]acrylic amide;

N-[4-(2,3,4-Trichlorophenoxy)butyl]acrylic amide;

N-[4-(2,4,5-Trichlorophenoxy)butyl]acrylic amide;

N-[4-(2,4,6-Trichlorophenoxy)butyl]acrylic amide;

N-[4-(2,4,6-Tribromophenoxy)butyl]acrylic amide;

N-[4-(2,3,4,6-Tetrachlorophenoxy)butyl]acrylic amide;

N-[4-(Pentachlorophenoxy)butyl]acrylic amide;

N-[4-(Pentabromophenoxy)butyl]acrylic amide;

N-[4-(3-Chlorobenzyloxy)butyl]acrylic amide;

N-[4-(4-Chlorobenzyloxy)butyl]acrylic amide;

N-[4-(4-Chloro-2-methylphenoxy)butyl]acrylic amide;

N-[4-(4-Chloro-3-methylphenoxy)butyl]acrylic amide;

N-[4-(2-Chloro-6-methylphenoxy)butyl]acrylic amide;

N-[4-(2-Bromo-4-methylphenoxy)butyl]acrylic amide;

N-[4-(2,4-Dichloro-6-methylphenoxy)butyl]acrylic amide;

N-[4-(2-Trifluoromethyl)phenoxy)butyl]acrylic amide;

N-[4-(2-Bromomethyl)-4,6-dibromophenoxy)butyl]acrylic amide;

N-[4-(4-Bromomethyl)-2,6-dibromophenoxy)butyl]acrylic amide;

N-[4-(Pentafluorobenzyloxy)butyl]acrylic amide;

N-[4-(4-Chloro-3,5-dimethylphenoxy)butyl]acrylic amide;

N-[4-(1-(4-Chlorophenylethoxy)butyl]acrylic amide;

N-[4-(2,4-Dichloro-3,5-dimethylphenoxy)butyl]acrylic amide;

1-(4-Acrylamidobutoxy)-4-chloronaphthalene;

N-[4-(4-tert-Butyl-2-chlorophenoxy)butyl]acrylic amide;

N-[4-(4-Chloro-5-methyl-isopropylphenoxy)butyl]acrylic amide;

2-(4-Acrylamidobutoxy)-1-bromonaphthalene;

2-(4-Acrylamidobutoxy)-6-bromonaphthalene;

N-[4-(2-Bromo-4-tert-butylphenoxy)butyl]acrylic amide;

1-(4-Acrylamidobutoxy)-2,4-dichloronaphthalene;

1-(4-Acrylamidobutoxy)-2,4-dibromonaphthalene;

N-[4-(2-Chloro-4-phenylphenoxy)butyl]acrylic amide;

N-[4-(2-Benzyl-4-chlorophenoxy)butyl]acrylic amide; etc.

As those obtained by substituting alkoxy groups to the aromatic rings of the above-described compounds and substituted derivatives obtained by bonding alkoxy groups to such aromatic rings via oxygen atoms, may for example be mentioned:

N-[4-(3-Methoxyphenoxy)butyl]acrylic amide;

N-[4-(4-Methoxyphenoxy)butyl]acrylic amide;

N-[4-(4-Methoxybenzyloxy)butyl]acrylic amide;

N-[4-(2-Methoxy-4-methylphenoxy)butyl]acrylic amide;

N-[4-(4-Ethoxyphenoxy)butyl]acrylic amide;

N-[4-(3,5-Dimethoxyphenoxy)butyl]acrylic amide;

N-[4-(2-Phenoxyethoxy)butyl]acrylic amide;

N-[4-(3,4-Dimethoxybenzyloxy)butyl]acrylic amide;

N-[4-(2-Benzyloxyethoxy)butyl]acrylic amide;

N-[4-(1-Methyl-2-phenoxyethoxy)butyl]acrylic amide;

N-[4-(2-(4-Methylphenoxy)ethoxy)butyl]acrylic amide;

N-[4-(3-n-Butoxyphenoxy)butyl]acrylic amide;

N-[4-(4-n-Butoxyphenoxy)butyl]acrylic amide;

N-[4-(4-Allyl-2-methoxyphenoxy)butyl]acrylic amide;

N-[4-(2-Methoxy-4-(1-propenyl)phenoxy)butyl]acrylic amide;

N-[4-(4-n-Pentyloxyphenoxy)butyl]acrylic amide;

N-[4-(4-n-Butoxybenzyloxy)butyl]acrylic amide;

N-[4-(2-tert-Butyl-4-methoxyphenoxy)butyl]acrylic amide;

N-[4-(4-n-Hexyloxyphenoxy)butyl]acrylic amide;

N-[4-(4-n-Heptyloxyphenoxy)butyl]acrylic amide;

N-[4-(4-n-Benzyloxyphenoxy)butyl]acrylic amide;

N-[4-(4-n-Octyloxyphenoxy)butyl]acrylic amide;

17-(4-Acrylamidobutoxy)-17-ethynyl-3-methoxy-1,3,5(10)-estratriene;

N-[4-(Phenoxy)polyethoxybutyl]acrylic amide [CH.sub.2 .dbd.CH--CO--NH--CH.sub.2).sub.4 O--CH.sub.2 CH.sub.2 --O).sub.n C.sub.6 H.sub.5 ; n=5, 7.5, 10, 15, 18, 20];

N-[4-((4-Nonylphenoxy)polyethoxy)butyl]acrylic amide [CH.sub.2 .dbd.CH--CO--NH --CH.sub.2 ).sub.4 O--CH.sub.2 CH.sub.2 --O).sub.n C.sub.6 H.sub.5 -C.sub.9 H.sub.19 ; n.dbd.5, 7.5, 10, 15, 18, 20 ];

N-[4-(2-(4-Chlorophenoxy)ethoxy)butyl]acrylic amide; and etc.

As those obtained by substituting cyano, nitro, amino and/or aminoalkyl groups to the aromatic rings of the above-described compounds or substituted derivatives formed by bonding such groups to the aromatic rings via azo groups, may for example be mentioned:

N-[4-(4-Cyanophenoxy)butyl]acrylic amide;

N-[4-(2-Nitrophenoxy)butyl]acrylic amide;

N-[4-(3-Nitrophenoxy)butyl]acrylic amide;

N-[4-(4-Nitrophenoxy)butyl]acrylic amide;

N-[4-(2-Chloro-4-nitrophenoxy)butyl]acrylic amide;

N-[4-(4-Chloro-2-nitrophenoxy)butyl]acrylic amide;

N-[4-(2,6-Dichloro-4-nitrophenoxy)butyl]acrylic amide;

N-[4-(2,4-Dinitrophenoxy)butyl]acrylic amide;

N-[4-(2,5-Dinitrophenoxy)butyl]acrylic amide;

N-[4-(4-Methyl-3-nitrophenoxy)butyl]acrylic amide;

N-[4-(2-Methyl-4-nitrophenoxy)butyl]acrylic amide;

N-[4-(3-Nitrobenzyloxy)butyl]acrylic amide;

N-[4-(4-Nitrobenzyloxy)butyl]acrylic amide;

N-[4-(4-Nitro-3-trifluoromethylphenoxy)butyl]acrylic amide;

N-[4-(3,5-Dinitro-2-methylphenoxy)butyl]acrylic amide;

N-[4-(2-Methoxy-5-nitrophenoxy)butyl]acrylic amide;

N-[4-(2-Anilinoethoxy)butyl]acrylic amide;

.alpha.-(4-Acrylamidobutoxy)benzyl cyanamide;

N-[4-(5-Dimethylamino-2-nitrophenoxy)butyl]acrylic amide;

N-[4-(3-(Dimethylamino)phenoxy)butyl]acrylic amide;

N-[4-(Dimethylaminomethylphenoxy)butyl]acrylic amide;

N-[4-(2-Amino-1-phenylpropoxy)butyl]acrylic amide;

N-[4-(2-(2-Methylphenylamino)ethoxy)butyl]acrylic amide;

2-(4-Acrylamidobutoxy)-1-nitronaphthalene;

1-(4-Acrylamidobutoxy)-2,4-dinitronaphthalene;

N-[4-(2-(N-ethylanilino)ethoxy)butyl]acrylic amide;

N-[4-(3-(diethylamino)phenoxy)butyl]acrylic amide;

N-[2-(4-Acrylamidobutoxy)ethyl]phthalimide;

N-[4-(1-(3-(Dimethylamino)phenyl)ethoxy)butyl]acrylic amide;

N-[4-(4-(2-(Dimethylamino)ethyl)phenoxy)butyl]acrylic amide;

N-[4-(2-(N-(2-Cyanoethyl)ani